New malignancies after squamous cell carcinoma and melanomas: A population-based study from Norway

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Robsahm, Trude E ^a   Karagas, Margaret R ^b   Rees, Judy R ^b   Syse, Astri ^c  

^a CANCER REGISTRY OF NORWAY   (Norway)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c Statisics Norway   (Norway)

Author keywords

Family; Malignant Melanoma; Population based; Second cancer; Sociodemographic factors; Squamous Cell Carcinoma

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVOR; CENTRAL NERVOUS SYSTEM TUMOR; COHORT ANALYSIS; COLON CANCER; CONTROLLED STUDY; CUTANEOUS MELANOMA; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; LEUKEMIA; LOWEST INCOME GROUP; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MIDDLE AGED; MOUTH CANCER; NORWAY; OUTCOME ASSESSMENT; PREDICTION; PRIMARY TUMOR; PROSTATE CANCER; RESIDENTIAL CARE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA; THYROID CANCER; YOUNG ADULT;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MELANOMA; MIDDLE AGED; NORWAY; POPULATION SURVEILLANCE; RISK FACTORS; SKIN NEOPLASMS; YOUNG ADULT;

EID: 84899089525     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-210     Document Type: Article

References (66)

1. de Vries E, Coebergh JW. Cutaneous malignant melanoma in Europe. Eur J Cancer 2004, 40:2355-2366. 10.1016/j.ejca.2004.06.003, 15519506.
2. Aceituno-Madera P, Buendia-Eisman A, Arias-Santiago S, Serrano-Ortega S. Changes in the incidence of skin cancer between 1978 and 2002. Actas Dermosifiliogr 2010, 101:39-46. 10.1016/j.ad.2009.05.001, 20109391.
3. Cancer Registry of Norway Cancer in Norway 2011-Cancer Incidence, Mortality, Survival and Prevalence in Norway 2013, Oslo: Cancer Registry of Norway, Cancer Registry of Norway.
4. Chang YM, Barrett JH, Bishop DT, Armstrong BK, Bataille V, Bergman W, Berwick M, Bracci PM, Elwood JM, Ernstoff MS, Gallagher RP, Green AC, Gruis NA, Holly EA, Ingvar C, Kanetsky PA, Karagas MR, Lee TK, le Marchand L, Mackie RM, Olsson H, Østerlind A, Rebbeck TR, Sasieni P, Siskind V, Swerdlow AJ, Titus-Ernstoff L, Zens MS, Newton-Bishop JA. Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls. Int J Epidemiol 2009, 38:814-830. 10.1093/ije/dyp166, 2689397, 19359257.
5. Leiter U, Garbe C. Epidemiology of melanoma and nonmelanoma skin cancer-the role of sunlight. Adv Exp Med Biol 2008, 624:89-103. 10.1007/978-0-387-77574-6_8, 18348450.
6. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med 2001, 344:975-983. 10.1056/NEJM200103293441306, 11274625.
7. Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, Vachon CM, Schild SE, McWilliams RR, Hand JL, Laman SD, Kottschade LA, Maples WJ, Pittelkow MR, Pulido JS, Cameron JD, Creagan ET. Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment. Mayo Clin Proc 2007, 82:490-513. 10.4065/82.4.490, 17418079.
8. Bentham G, Aase A. Incidence of malignant melanoma of the skin in Norway, 1955-1989: associations with solar ultraviolet radiation, income and holidays abroad. Int J Epidemiol 1996, 25:1132-1138. 10.1093/ije/25.6.1132, 9027516.
9. Nugent Z, Demers AA, Wiseman MC, Mihalcioiu C, Kliewer EV. Risk of second primary cancer and death following a diagnosis of nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev 2005, 14:2584-2590. 10.1158/1055-9965.EPI-05-0379, 16284382.
10. Curtis RE, Freedman DM, Ron E, Ries LA, Hacker DG, Edwards BK, Tucker MA, Fraumeni JF. New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000 2006, Bethesda, MD: National Institute of Health, NIH Publ. 05-5302.
11. Goggins W, Daniels GH, Tsao H. Elevation of thyroid cancer risk among cutaneous melanoma survivors. Int J Cancer 2006, 118:185-188. 10.1002/ijc.21300, 16049985.
12. Wassberg C, Thorn M, Yuen J, Ringborg U, Hakulinen T. Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden. Br J Cancer 1996, 73:255-259. 10.1038/bjc.1996.45, 2074325, 8546916.
13. Wassberg C, Thorn M, Yuen J, Ringborg U, Hakulinen T. Second primary cancers in patients with squamous cell carcinoma of the skin: a population-based study in Sweden. Int J Cancer 1999, 80:511-515. 10.1002/(SICI)1097-0215(19990209)80:4<511::AID-IJC5>3.0.CO;2-P, 9935149.
14. Swerdlow AJ, Storm HH, Sasieni PD. Risks of second primary malignancy in patients with cutaneous and ocular melanoma in Denmark, 1943-1989. Int J Cancer 1995, 61:773-779. 10.1002/ijc.2910610606, 7790110.
15. Bradford PT, Freedman DM, Goldstein AM, Tucker MA. Increased risk of second primary cancers after a diagnosis of melanoma. Arch Dermatol 2010, 146:265-272. 3076705, 20231496.
16. Wheless L, Black J, Alberg AJ. Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review. Cancer Epidemiol Biomarkers Prev 2010, 19:1686-1695. 10.1158/1055-9965.EPI-10-0243, 2901413, 20570907.
17. Cantwell MM, Murray LJ, Catney D, Donnelly D, Autier P, Boniol M, Fox C, Middleton RJ, Dolan OM, Gavin AT. Second primary cancers in patients with skin cancer: a population-based study in Northern Ireland. Br J Cancer 2009, 100:174-177. 10.1038/sj.bjc.6604842, 2634689, 19127269.
18. Adami J, Frisch M, Yuen J, Glimelius B, Melbye M. Evidence of an association between non-Hodgkin's lymphoma and skin cancer. Br Med J 1995, 310:1491-1495.
19. Hemminki K, Dong C. Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin. Arch Dermatol 2000, 136:647-651.
20. Karagas MR, Greenberg ER, Mott LA, Baron JA, Ernster VL. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer. Cancer Epidemiol Biomarkers Prev 1998, 7:157-161.
21. Rosenberg CA, Greenland P, Khandekar J, Loar A, Ascensao J, Lopez AM. Association of nonmelanoma skin cancer with second malignancy. Cancer 2004, 100:130-138. 10.1002/cncr.11874, 14692033.
22. Lens MB, Newton-Bishop JA. An association between cutaneous melanoma and non-Hodgkin's lymphoma: pooled analysis of published data with a review. Ann Oncol 2005, 16:460-465. 10.1093/annonc/mdi080, 15642704.
23. Maitra SK, Gallo H, Rowland-Payne C, Robinson D, Moller H. Second primary cancers in patients with squamous cell carcinoma of the skin. Br J Cancer 2005, 92:570-571. 2362093, 15611792.
24. Chen J, Ruczinski I, Jorgensen TJ, Yenokyan G, Yao Y, Alani R, Liégeois NJ, Hoffman SC, Hoffman-Bolton J, Strickland PT, Helzlsouer KJ, Alberg AJ. Nonmelanoma skin cancer and risk for subsequent malignancy. J Natl Cancer Inst 2008, 100:1215-1222. 10.1093/jnci/djn260, 2720713, 18728282.
25. Spanogle JP, Clarke CA, Aroner S, Swetter SM. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study. J Am Acad Dermatol 2010, 62:757-767. 10.1016/j.jaad.2009.07.039, 20223559.
26. Troyanova P, Danon S, Ivanova T. Nonmelanoma skin cancers and risk of subsequent malignancies: a cancer registry-based study in Bulgaria. Neoplasma 2002, 49:81-85.
27. Balamurugan A, Rees JR, Kosary C, Rim SH, Li J, Stewart SL. Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin. J Am Acad Dermatol 2011, 65(Suppl 1):69-77.
28. Frisch M, Melbye M. New primary cancers after squamous cell skin cancer. Am J Epidemiol 1995, 141:916-922.
29. Levi F, randimbison L, La Vecchia C, Erler G, Te V-C. Incidence of invasive cancers following squamous cell skin cancer. Am J Epidemiol 1997, 146:734-739. 10.1093/oxfordjournals.aje.a009349, 9366621.
30. Song F, Quresti AA, Giovannucci EL, Fuchs CS, Chen WY, Stampfer MJ, Han J. Risk of a second primary cancer after non-melanoma skin cancer in white men and women: a prospective cohort study. PLoS Med 2013, 10:e1001433. 10.1371/journal.pmed.1001433, 3635863, 23630459.
31. Tuohimaa P, Pukkala E, Scelo G, Olsen JH, Brewster DH, Hemminki K, Tracey E, Weiderpass E, Kliewer EV, Pompe-Kirn V, McBride ML, Martos C, Chia KS, Tonita JM, Jonasson JG, Boffetta P, Brennan P. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation. Eur J Cancer 2007, 43:1701-1712. 10.1016/j.ejca.2007.04.018, 17540555.
32. de Vries E, Soerjomataram I, Houterman S, Louwman MW, Coebergh JW. Decreased risk of prostate cancer after skin cancer diagnosis: a protective role of ultraviolet radiation?. Am J Epidemiol 2007, 165:966-972. 10.1093/aje/kwk084, 17255116.
33. Levi F, Randimbison L, Te VC, Conconi MM, La VC. Risk of prostate, breast and colorectal cancer after skin cancer diagnosis. Int J Cancer 2008, 123:2899-2901. 10.1002/ijc.23816, 18770862.
34. Soerjomataram I, Louwman WJ, Lemmens VE, Coebergh JW, de Vries E. Are patients with skin cancer at lower risk of developing colorectal or breast cancer?. Am J Epidemiol 2008, 167:1421-1429. 10.1093/aje/kwn077, 18424428.
35. Grant WB. A meta-analysis of second cancers after a diagnosis of nonmelanoma skin cancer: additional evidence that solar ultraviolet-B irradiance reduces the risk of internal cancers. J Steroid Biochem Mol Biol 2007, 103:668-674. 10.1016/j.jsbmb.2006.12.030, 17208438.
36. Hughes AM, Armstrong BK, Vajdic CM, Turner J, Grulich AE, Fritschi L, Milliken S, Kaldor J, Benke G, Kricker A. Sun exposure may protect against non-Hodgkin lymphoma: a case-control study. Int J Cancer 2004, 112:865-871. 10.1002/ijc.20470, 15386383.
37. Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: A review (United States). Cancer Causes Control 2005, 16:83-95. 10.1007/s10552-004-1661-4, 15868450.
38. Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer?. Int J Epidemiol 1980, 9:227-231. 10.1093/ije/9.3.227, 7440046.
39. Larsen IK, Smastuen M, Johannesen TB, Langmark F, Parkin DM, Bray F, Møller B. Data quality at the cancer registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009, 45:1218-1231. 10.1016/j.ejca.2008.10.037, 19091545.
40. Robsahm TE, Tretli S. Cutaneous malignant melanoma in Norway: variation by region of residence before and after the age 17. Cancer Causes Control 2001, 12:569-576. 10.1023/A:1011287918405, 11519765.
41. StataCorp Stata Statistical Software: Release 12 2011, College Station, TX: StataCorp LP, StataCorp.
42. Allison PD. Survival Analysis Using SAS. A Practical Guide 1995, Cary, NC: SAS Institute Inc.
43. Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 2004, 150:179-185. 10.1111/j.1365-2133.2004.05708.x, 14996086.
44. McKenna DB, Doherty VR, McLaren KM, Hunter JA. Malignant melanoma and lymphoproliferative malignancy: is there a shared aetiology?. Br J Dermatol 2000, 143:171-173. 10.1046/j.1365-2133.2000.03610.x, 10886155.
45. McMichael AJ, Giles GG. Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma?. Br J Cancer 1996, 73:945-950.
46. Boldeman C, Brandt L, Berg L, Ekbom A, Hall P. Risk of non-Hodgkin's lymphoma and skin malignancies in patients diagnosed with cataract. Eur J Cancer Prev 2004, 13:281-285. 10.1097/01.cej.0000136570.70998.13, 15554556.
47. Hemminki K, Jiang Y, Steineck G. Skin cancer and non-Hodgkin's lymphoma as second malignancies. markers of impaired immune function?. Eur J Cancer 2003, 39:223-229. 10.1016/S0959-8049(02)00595-6, 12509955.
48. Werkmeister J, Phillips G, McCarthy W, Hersey P. Suppressor cell activity in melanoma patients. II. Concanavalin A-induced suppressor cells in relation to tumor growth and suppressor T-cell subsets. Int J Cancer 1981, 28:11-15. 10.1002/ijc.2910280103, 6458570.
49. Vanhaelen CP, Fisher RI. Increased sensitivity of T cells to regulation by normal suppressor cells persists in long-term survivors with Hodgkin's disease. Am J Med 1982, 72:385-390. 10.1016/0002-9343(82)90493-4, 6460444.
50. Travis LB, Curtis RE, Glimelius B, Holowaty E, van Leeuwen FE, Lynch CF, Adami J, Gospodarowicz M, Wacholder S, Inskip P, Tucker MA, Fraumeni JF, Boice JD. Second cancers among long-term survivors of non-Hodgkin's lymphoma. J Natl Cancer Inst 1993, 85:1932-1937. 10.1093/jnci/85.23.1932, 8230284.
51. Grodstein F, Speizer FE, Hunter DJ. A prospective study of incident squamous cell carcinoma of the skin in the nurses' health study. J Natl Cancer Inst 1995, 87:1061-1066. 10.1093/jnci/87.14.1061, 7616597.
52. Goggins W, Gao W, Tsao H. Association between female breast cancer and cutaneous melanoma. Int J Cancer 2004, 111:792-794. 10.1002/ijc.20322, 15252852.
53. Faggiano F, Partanen T, Kogevinas M, Boffetta P. Socioeconomic differences in cancer incidence and mortality. Lyon: IARC Sci Publ 1997, 138:65-176.
54. Kravdal T. Social inequalities in cancer survival. Tidskr Nor Lægeforen 1999, 119:1577-1583.
55. Hiatt RA, Krieger N, Sagebiel RW, Clark WH, Mihm MC. Surveillance bias and the excess risk of malignant melanoma among employees of the Lawrence Livermore National Laboratory. Epidemiology 1993, 4:43-47. 10.1097/00001648-199301000-00009, 8420580.
56. Robsahm TE, Bergva G, Hestvik UE, Møller B. Sex differences in rising trends of cutaneous malignant melanoma in Norway, 1954-2008. Melanoma Res 2013, 23:70-78. 10.1097/CMR.0b013e32835c7e48, 23222548.
57. Lehtonen L, Eskola J, Vainio O, Lehtonen A. Changes in lymphocyte subsets and immune competence in very advanced age. J Gerontol 1990, 45:108-112.
58. Thivolet J, Nicolas JF. Skin ageing and immune competence. Br J Dermatol 1990, 122(Suppl 35):77-81.
59. Nasser N, UVB Susceptibility in malignant melanoma. An Bras Dermatol 2010, 85:843-848. 10.1590/S0365-05962010000600010, 21308308, UVB.
60. Kravdal T. Children, family and cancer survival in Norway. Int J Cancer 2003, 105:261-266. 10.1002/ijc.11071, 12673689.
61. Goldstein AM, Landi MT, Tsang S, Fraser MC, Munroe DJ, Tucker M. Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations. Cancer Epidemiol Biomarkers Prev 2005, 14:2208-2212.
62. Zhang H, Bermejo JL, Sundquist J, Hemminki K. Modification of second cancer risk after mailignant melanoma by parental history of cancer. Br J Cancer 2008, 99:536-538. 10.1038/sj.bjc.6604489, 2527798, 18628759.
63. Siskind V, Hughes MC, Palmer JM, Symmons JM, Aitken JF, Martin NG, Hayward NK, Whiteman DC. Nevi, family history, and fair skin increase the risk of second primary melanoma. J Invest Dermatol 2011, 131:461-467. 10.1038/jid.2010.298, 3045696, 20944647.
64. Cambell SM, Roland MO. Why do people consult the doctor?. Fam Pract 1996, 13:75-83. 10.1093/fampra/13.1.75, 8671107.
65. Holvik K, Ahmed LA, Forsmo S, Gjesdal CG, Grimnes G, Samuelsen SO, Schei B, Blomhoff R, Tell GS, Meyer HE. Low serum levels of 25-hydroxyvitamin D predict Hip fracture in the elderly: a NOREPOS study. J Clin Endocrinol Metab 2013, 98:3341-3350. 10.1210/jc.2013-1468, 23678033.
66. Idorn LW, Datta P, Heydenreich J, Philipsen PA, Wulf HC. A 3-year follow-up of Sun behavior in patients with cutaneous malignant melanoma. JAMA Dermatol 2013, [Epub ahead of print].